Hargreave Hale AIM VCT (HHV) Competitors GBX 32.25 -0.95 (-2.86%) As of 12:35 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesBuy This Stock HHV vs. RTW, OTV2, UEM, FSFL, ATR, POLR, AIE, JCH, GHE, and BHGGShould you be buying Hargreave Hale AIM VCT stock or one of its competitors? The main competitors of Hargreave Hale AIM VCT include RTW Biotech Opportunities (RTW), Octopus Titan VCT (OTV2), Utilico Emerging Markets Trust (UEM), Foresight Solar (FSFL), Schroder Asian Total Return Inv. (ATR), Polar Capital (POLR), Ashoka India Equity Investment (AIE), JPMorgan Claverhouse (JCH), Gresham House (GHE), and BH Global (BHGG). These companies are all part of the "asset management" industry. Hargreave Hale AIM VCT vs. Its Competitors RTW Biotech Opportunities Octopus Titan VCT Utilico Emerging Markets Trust Foresight Solar Schroder Asian Total Return Inv. Polar Capital Ashoka India Equity Investment JPMorgan Claverhouse Gresham House BH Global Hargreave Hale AIM VCT (LON:HHV) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Which has more risk and volatility, HHV or RTW? Hargreave Hale AIM VCT has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Is HHV or RTW more profitable? RTW Biotech Opportunities has a net margin of 664.38% compared to Hargreave Hale AIM VCT's net margin of 264.25%. RTW Biotech Opportunities' return on equity of 25.18% beat Hargreave Hale AIM VCT's return on equity.Company Net Margins Return on Equity Return on Assets Hargreave Hale AIM VCT264.25% -4.34% -8.44% RTW Biotech Opportunities 664.38%25.18%-0.47% Which has preferable earnings and valuation, HHV or RTW? RTW Biotech Opportunities has higher revenue and earnings than Hargreave Hale AIM VCT. Hargreave Hale AIM VCT is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHargreave Hale AIM VCT-£2.49M-47.34-£6.58M-£1.80-17.92RTW Biotech Opportunities£38.73M0.12£14.09B£0.1112.73 Does the media refer more to HHV or RTW? In the previous week, Hargreave Hale AIM VCT had 2 more articles in the media than RTW Biotech Opportunities. MarketBeat recorded 3 mentions for Hargreave Hale AIM VCT and 1 mentions for RTW Biotech Opportunities. RTW Biotech Opportunities' average media sentiment score of 1.35 beat Hargreave Hale AIM VCT's score of 0.42 indicating that RTW Biotech Opportunities is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hargreave Hale AIM VCT 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RTW Biotech Opportunities 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in HHV or RTW? 6.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.2% of Hargreave Hale AIM VCT shares are held by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryRTW Biotech Opportunities beats Hargreave Hale AIM VCT on 12 of the 13 factors compared between the two stocks. Get Hargreave Hale AIM VCT News Delivered to You Automatically Sign up to receive the latest news and ratings for HHV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HHV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HHV vs. The Competition Export to ExcelMetricHargreave Hale AIM VCTAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£117.93M£1.48B£6.62B£2.91BDividend Yield8.57%4.45%4.18%5.19%P/E Ratio-17.92988.82177.502,379.58Price / Sales-47.341,779.511,258.124,174.46Price / Cash4.0360.62127.5927.93Price / Book0.801.395.276.89Net Income-£6.58M£265.04M£1.23B£5.89B7 Day PerformanceN/A0.18%0.02%0.23%1 Month Performance-0.62%1.50%2.57%50.01%1 Year Performance-18.66%6.90%24.33%150.47% Hargreave Hale AIM VCT Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HHVHargreave Hale AIM VCTN/AGBX 32.25-2.9%N/A-15.1%£117.93M-£2.49M-17.92N/ANews CoverageDividend IncreaseHigh Trading VolumeRTWRTW Biotech OpportunitiesN/AGBX 1.40-0.3%N/A-9.7%£469.94M£2.12B3.344,971Positive NewsOTV2Octopus Titan VCTN/AGBX 29.50flatN/A-44.6%£469.73M-£147.88M-2.6130News CoverageUEMUtilico Emerging Markets TrustN/AGBX 248.22+0.1%N/A+12.6%£467.83M£33.05M22.52N/APositive NewsFSFLForesight SolarN/AGBX 82.46-0.4%N/A-12.5%£467.06M£14.27M74.23N/ADividend AnnouncementATRSchroder Asian Total Return Inv.N/AGBX 495.64+0.1%N/A+10.5%£463.55M£75.15M6.9413,500News CoveragePOLRPolar Capital2.3465 of 5 starsGBX 474+0.3%GBX 555+17.1%-10.5%£453.06M£208.88M11.05135AIEAshoka India Equity InvestmentN/AGBX 272.70-0.5%N/A-5.9%£452.67M£146.85M3.72N/AJCHJPMorgan ClaverhouseN/AGBX 813.10+0.4%N/A+11.9%£452.00M£62.40M7.83N/AGHEGresham HouseN/AN/AN/AN/A£451.55M£86.03M3,055.56216BHGGBH GlobalN/AN/AN/AN/A£444.68M£837K5.12N/A Related Companies and Tools Related Companies RTW Biotech Opportunities Competitors Octopus Titan VCT Competitors Utilico Emerging Markets Trust Competitors Foresight Solar Competitors Schroder Asian Total Return Inv. Competitors Polar Capital Competitors Ashoka India Equity Investment Competitors JPMorgan Claverhouse Competitors Gresham House Competitors BH Global Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HHV) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hargreave Hale AIM VCT Please log in to your account or sign up in order to add this asset to your watchlist. Share Hargreave Hale AIM VCT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access